Target intelligence / Profile preview

β-catenin (CTNNB1)

Target
CTNNB1
Molecular classification
Transcription factor coactivator, Adherens junction protein, Wnt pathway effector
01

Overview

β-catenin stabilization in macrophages refers to the process by which levels of β-catenin protein increase and remain active within macrophages. This stabilization activates the canonical Wnt/β-catenin signaling pathway, leading to nuclear translocation and transcriptional changes in macrophage behavior. β-catenin is a multifunctional protein primarily known for its roles in cell adhesion and in regulating gene transcription downstream of the Wnt signaling pathway. In macrophages, stabilization of β-catenin means that the protein escapes degradation, accumulates in the cytoplasm, and translocates to the nucleus, where it regulates gene expression through interaction with TCF/LEF transcription factors. This process modulates macrophage phenotype, including the shift toward an alternatively activated (M2) state and impacts immune responses, tissue repair, fibrosis, and tumor progression.

Other names
Beta-cateninCTNNB1Armadillo protein
02

Mechanism of action

Inhibition of β-catenin–dependent gene transcription; Promotion or blockade of β-catenin stability/degradation; Modulation of exosome release affecting cell signaling

03

Biological functions

Signal transduction (Wnt signaling)Gene transcription regulationCell adhesionImmune response modulation (macrophage polarization, Treg induction)Cell proliferation
04

Disease associations

Cancer (tumor progression, metastasis)Inflammation (regulation via NF-κB)Fibrosis (kidney, tissue injury)InfectionTissue repair and regeneration
05

Safety considerations

Risk of disrupting tissue homeostasis and repairPotential promotion of tumor growth/metastasis if inappropriately activatedEffects on immune tolerance (Treg induction)Off-target effects in other cell types
06

Interacting drugs

ICG-001

2 more in the full profile.

07

Biomarkers

Nuclear β-catenin (activation marker)STAT3 phosphorylation (downstream effect)Expression of Wnt target genes (TCF/LEF activity)Surface markers (TSG101, CD9, CD63 in exosomes)

Beyond the preview

Go deeper on β-catenin (CTNNB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on β-catenin (CTNNB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call